Psoriasis (PsO) has been associated with a range of psychiatric disorders, yet the availability of national-level data remains limited and outdated. This study utilzied the 2023 National Health Interview Survey recent data to elucidate the psychological impact of PsO. This cross-sectional study compared participants with self-reported PsO to those without using Wilcoxon rank sum and chi-square tests. Adjusted logistic regression models assessed odds for life satisfaction, depression, anxiety, and use of medication/therapy for mental health reasons. Weighted analysis demonstrated 7,424,788 participants with self-reported PsO of which 51% were men and 79% identified as White (79%). Compared to those without PsO, those with PsO had higher odds of reporting dissatisfaction with life (OR = 2.07 95% CI: 1.52–2.83, p < 0.001), anxiety (OR = 2.06, 95% CI: 1.68–2.53, p < 0.001), depression (OR = 1.80, 95% CI: 1.52–2.14, p < 0.001) and use of mental health therapy or medication (OR = 1.76, 95% CI: 1.42–2.18, p < 0.001). Our national analysis shows that PsO is associated with a significant mental health burden doubling the odds for anxiety and life dissatisfaction and increasing the likelihood for depression and mental health treatment use.
Alani et al. (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: